Pharma & Biotech

First reported 6 hours ago - Updated 58 mins ago - 23 reports

Biotech giant axes up to 2,900 jobs

Biologic drug-maker Amgen is to shed 12 to 15% of its worldwide workforce and close four sites, despite reporting stellar second-quarter results that trounced Wall Street expectations.Amgen, which has more than 500 staff working at its UK sites in Cambridge ... [Published BT.com - 58 mins ago]
First reported 15 hours ago - Updated 1 hour ago - 5 reports

Eliquis gets expanded approval in Europe for deep vein thrombosis, pulmonary embolism

US Bristol-Myers Squibb Co (NYSE:BMY) and PfizerInc (NYSE:PFE) said Tuesday that their oral selective Factor Xainhibitor, Eliquis (apixaban), had been cleared by the EuropeanCommission (EC) to treat deep vein thrombosis (DVT) and pulmonaryembolism (PE), ... [Published MedCity News - 1 hour ago]
First reported 13 hours ago - Updated 1 hour ago - 8 reports

Application for First Malaria Vaccine Submitted to EMA

British drug giant GlaxoSmithKline has submitted the world’s first application for approval of a malaria vaccine, a product developed in partnership with the Bill & Melinda Gates Foundation and the PATH Malaria Vaccine Initiative.The drugmaker said that ... [Published FDA News - 1 hour ago]
First reported 21 hours ago - Updated 2 hours ago - 11 reports

Roche wins Euorpean approval for new leukaemia drug

Roche's Gazyvaro (obinutuzumab) has been approved in Europe to treat the blood cancer chronic lymphocytic leukaemia (CLL).The European Commission confirmed an earlier recommendation from regulators that backed the antibody in combination with chlorambucil ... [Published PMLive - 2 hours ago]
First reported Jul 29 2014 - Updated 2 hours ago - 39 reports

Pfizer set to launch a second attempt to buy AstraZeneca

Pfizer is likely to launch a second attempt to buy AstraZeneca despite reporting a poor set of financial figures.Profits at the US drugs giant fell by 25 per cent in the first half of the year, and it was unable to announce any new blockbuster drugs.The ... [Published This Is Money - 4 hours ago]
First reported 15 hours ago - Updated 5 hours ago - 8 reports

Polaris names former Pfizer exec as only female partner among area's top VC firms

Helping reverse a nationwide trend of fewer female venture capitalists in recent years, Polaris Partners has named the only female partner currently at any of the area’s top VC firms... ... [Published Crawford Financial Planning - 5 hours ago]
First reported 13 hours ago - Updated 5 hours ago - 5 reports

FDA cites inspection observations at Impax' manufacturing plant in Taiwan

Impax Laboratories said Tuesday that the FDA raised concerns over the company's manufacturing site in Taiwan as part of an inspection ahead of a decision on whether to approve its Parkinson's disease therapy Rytary (carbidopa/levodopa). "We are already ... [Published FirstWord Pharma - 5 hours ago]
First reported 20 hours ago - Updated 10 hours ago - 7 reports

Merck Serono Kicks Off Study of Merkel Cell Carcinoma Drug

Merck Serono, the biopharmaceutical division of Merck, announced the initiation of an international Phase 2 study designed to assess the efficacy and safety of MSB0010718C, an investigational fully human IgG1 monoclonal antibody that binds to programmed ... [Published Drug Discovery and Development - 10 hours ago]
First reported Jul 28 2014 - Updated 15 hours ago - 12 reports

LDC exits Penn Pharmaceuticals in GBP127million sale to Packaging Coordinators

Mid-market private equity firm LDC has exchanged contracts to sell its stake in pharmaceutical manufacturer Penn Pharmaceuticals in a GBP127million transaction with Packaging Coordinators.LDC took a significant stake in Penn in April 2007, investing GBP33million ... [Published Private Equity Wire - 15 hours ago]
First reported Jul 28 2014 - Updated 21 hours ago - 19 reports

AstraZeneca doubles down on blood tests for cancer with Roche, Qiagen deals

LONDON (Reuters) - AstraZeneca has signed up Roche and Qiagen to develop two separate diagnostic tests, both using simple blood samples, to identify patients who will benefit from its lung cancer drugs.Currently testing patients to see if their tumors ... [Published MedCity News - Jul 29 2014]
First reported Jul 28 2014 - Updated Jul 29 2014 - 36 reports

Reckitt Benckiser to spin off pharmaceutical unit

Operating profits at Reckitt's pharma division fell 20 per cent in the six months to June 30 2014 to £183million, as its heroine treatment Suboxone was hit by copycat versions.The division will be listed on the London Stock Exchange within 12 months, ... [Published NewsRT.co.uk - Jul 29 2014]
First reported Jul 28 2014 - Updated Jul 28 2014 - 19 reports

GlaxoSmithKline plc Lowered to “Underperform” at Mainfirst (GSK)

GlaxoSmithKline plc (NYSE:GSK)A number of other firms have also recently commented on GSK. Analysts at Bank of America downgraded shares of GlaxoSmithKline plc from a "buy" rating to a "neutral" rating in a research note on Monday. Separately, analysts ... [Published American Banking News - Jul 28 2014]

Quotes

...communities have been very supportive, so it is with great reluctance that we acknowledge the need to exit," said Robert A Bradway, chairman & CEO. "At each site, we are actively engaging in discussions with third-parties about potential future use of the facilities."
...health care providers achieve faster and more accurate test results," said  Brian Blaser , executive vice president, Diagnostics Products, Abbott. "Abbott is focused on providing an integrated diagnostic solution, powered by innovations that can help our customers channel change into growth and ensure exceptional performance."
"We view the restructuring plan and 15% workforce reduction announced as a positive that will help the company improve its cost structure while continuing to invest in the pipeline and key product launches" Citigroup analyst Dr Yaron Werber wrote to investors
...operations and goals for sustainability when it comes to the marketing supply chain," said Gerald Olivier , global account director, InnerWorkings. "We look forward to delivering a consistent, unified brand experience that brings innovation, value and results, while ensuring compliance from a CSR perspective."

More Content

All (32683) | News (32246) | Reports (1) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (153)
sort by: Date | Relevance
FDA Approves Ryanodex, New MH Drug [Published Pharmacy Practice News - 6 mins ago]
FDA expanded use of eye drug [Published Wall Street Business Network - 12 mins ago]
Amgen to Lay off up to 2,900; 2Q Revenues up 11... [Published Pharmaceutical Manufacturing Magazine - 17 mins ago]
Vertex Pharmaceuticals Incorporated's (VRTX) CE... [Published Seeking Alpha - 21 mins ago]
Amgen (AMGN) CEO Bob Bradway on Q2 2014 Results... [Published Seeking Alpha - 21 mins ago]
Aegerion Pharmaceuticals' (AEGR) CEO Marc Beer ... [Published Seeking Alpha - 21 mins ago]
Neogen launches streamlined dairy heifer genomi... [Published Agri View - 25 mins ago]
Hospitals making huge profit on simple disposab... [Published PharmaBiz - 26 mins ago]
India to set up National Bio-material Center to... [Published PharmaBiz - 26 mins ago]
Industry seeks incentives for SMEs of APIs to b... [Published PharmaBiz - 26 mins ago]
IPA president optimistic of robust regulatory l... [Published PharmaBiz - 26 mins ago]
CDSCO to launch IT-enabled system for online su... [Published PharmaBiz - 26 mins ago]
PRICE & QUALITY OF DEVICES [Published PharmaBiz - 26 mins ago]
LA JOLLA PHARMACEUTICAL REPORTS ACQUISITION BY ... [Published HighBeam Research - 29 mins ago]
Pharmaceutical composition of nanoparticles [Published Free Patents Online - 36 mins ago]
Pharmaceutical delivery systems for treatment o... [Published Free Patents Online - 36 mins ago]
Stable pharmaceutical composition containing do... [Published Free Patents Online - 36 mins ago]
NHGRI holds workshop on the future of the genom... [Published National Human Genome Research Institute - 45 mins ago]
Abbott to Showcase Innovations to Help Labs Sol... [Published PharmaAsia - 54 mins ago]
Biotech giant axes up to 2,900 jobs [Published BT.com - 58 mins ago]
Sanofi and InnerWorkings Sign Global Marketing ... [Published Print + Promo - 58 mins ago]
FDA lodges 11 FIRs against pharmacists [Published Asian Age - 1 hour ago]
Mount Gilead High School to hold “Welcome Back ... [Published Morrow County Sentinel - 1 hour ago]
RSS wings oppose GM crop trials, government say... [Published DNA India - 1 hour ago]
Eliquis gets expanded approval in Europe for de... [Published MedCity News - 1 hour ago]
Amgen to cut 2,400-2,900 jobs mostly in US [Published GlobalPost - 1 hour ago]
Endocyte's (ECYT) CEO Ron Ellis on Q2 2014 Resu... [Published Seeking Alpha - 1 hour ago]
7/30/2014: Nation: Javadekar sidesteps claim th... [Published Hindustan Times - 1 hour ago]
Letter: Amendment 1 another fence by government... [Published Springfield News-Leader - 1 hour ago]
WS flat as telecom gains offset by earnings [Published Nigeria Punch - 1 hour ago]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
From Sprint And TechStars To The FDA, A Look At... [Published TechCrunch - Oct 10 2013]
The health-care industry in the U.S. is broken, and considering the industry itself represents some 18 percent of the U.S. economy, it’s a sizable problem. While other sectors have begun to adapt, health care has managed to resist change — particularly ...
1

Press Releases

sort by: Date | Relevance
Using genomics to make personalized, safer medi... [Published PR Newswire - Feb 03 2014]
Endo Completes Acquisition of Specialty Generic... [Published PR Newswire - Feb 03 2014]
10 Reasons Why Biometric Exit May Advance in 2014 [Published PR Newswire - Feb 03 2014]
Regado Biosciences Announces $20 Million Privat... [Published PR Newswire - Jan 31 2014]
Novo Nordisk Promotes Eddie Williams to Senior ... [Published PR Newswire - Jan 30 2014]
1 2 3 4 5 6 7 8 9 10 ...
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.